PerryGordonFineMD
Anesthesiology • Salt Lake City, UTHospice & Palliative Medicine, Pain Medicine
Professor, Anesthesiology, University of Utah School of Medicine
Dr. Fine is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
50 N Medical Dr
Salt Lake City, UT 84132Phone+1 801-581-6393
Education & Training
University of Utah HealthResidency, Anesthesiology, 1982 - 1984
Sutter Santa Rosa Regional HospitalInternship, Transitional Year, 1981 - 1982
Virginia Commonwealth University School of MedicineClass of 1981
Certifications & Licensure
UT State Medical License 1982 - 2026
CO State Medical License 1995 - 1997- American Board of Anesthesiology Anesthesiology
- American Board of AnesthesiologyHospice and Palliative Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- 14 citationsImpact of opioid-induced constipation on healthcare resource utilization and costs for cancer pain patients receiving continuous opioid therapyPerry G. Fine, Yen-Wen Chen, Eric Wittbrodt, Catherine Datto
Supportive Care in Cancer. 2019-02-01 - 3 citationsOpioid utilization patterns among patients with cancer and non-cancer pain.Catherine Datto, Yiqun Hu, Eric Wittbrodt, Perry G. Fine
Journal of Opioid Management. 2019-01-01 - 5 citationsEffective Treatments for Pain in the Older PatientPaul J. Christo, Sean Li, Stephen J. Gibson, Perry G. Fine, Haroon Hameed
Current Pain and Headache Reports. 2018-12-13
Press Mentions
Perry G. Fine, MD Pain Lecture Series Offers Continuing Education for Healthcare ProfessionalsOctober 3rd, 2016
My View: Will Utah Be the Nation’s Next Lemming State on 'Medical' Marijuana?December 28th, 2015
A Cost Utilization Analysis of Intrathecal Therapy for Refractory Cancer Pain: Identifying Factors Associated with Cost BenefitApril 11th, 2013
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
